Mediq: een betrouwbare partner in zorg
Mediq is een toonaangevende – van oorsprong Nederlandse – multinational in de wereld van gezondheids- en thuiszorg. Mediq levert medische hulpmiddelen, zorg en medicijnen tot in de woonkamer, maar ook aan ziekenhuizen, zorginstellingen en apotheken. Mediq is een innovatieve organisatie. Dat moet ook wel, want de technologische ontwikkelingen, demografische verschuivingen, medische doorbraken en wetgeving zullen de wereld van de gezondheidszorg blijven veranderen.
De geschiedenis van Mediq
Mediq is opgericht in 1899 in Nederland. In de afgelopen jaren zijn er meerdere overnames geweest. Mediq heeft nu 4000 werknemers en in alle landen waar ze actief zijn een marktleiderspositie. Omdat de markten en de wet- en regelgeving van de landen waarin Mediq actief is zo verschilt, behouden de lokale organisaties veel autonomie. De uitdaging is om de juiste mate van cohesie tussen deze lokale ondernemingen te realiseren. Mediq is onderdeel van Advent International, een grote private equity investeerder.
Technologische ontwikkelingen, demografische verschuivingen, nieuwe medicijnen of methoden en wet- en regelgeving veranderen continu in de gezondheidszorg. Door het bij elkaar brengen van alle verschillende stakeholders in dit debat, zoals leveranciers, professionals, patiëntenorganisatie en verzekeringen, is Mediq in staat om nieuwe business-modellen, initiatieven en aanpakken te introduceren die de kwaliteit van de zorg verbeteren.
Under the influence of technological, demographical and political factors, healthcare is changing more rapidly and drastically than ever. Mediq, a leading player in health and home care across fourteen countries, responds by introducing new business models, initiatives and approaches. Since Mediq was acquired by private equity firm Advent International in 2013, the company has transformed from a pharmaceutical wholesale business to a medical supplies and service provider. As well as a change in positioning, the company has been through an organizational transformation program in order to create more synergy through centralization.
Founded in 1899 in the Netherlands, Mediq became a major international player through a combination of organic and inorganic growth. As a trusted partner for millions of patients, care professionals and health insurers, they continually focus on improving the outcome, affordability and customer experience of healthcare.
Mediq strongly believes in value-based healthcare, which means with everything they do, they aim to serve three purposes:
- Improve medical results in the treatment of patients
- Bringing down costs
- Improve the customer experience
The rise of home care
Through a deep understanding of the market dynamics, regulations and reimbursement structures, Mediq has achieved a leading position in supplying medical devices and innovative services in every country in which it is active. Looking ahead, the ambition is to be the leading international direct-to-patient supplier.
The decision to focus on a direct-to-patient positioning is based on the insight that over the coming years, Mediq’s market landscape will continue to change at an ever-increasing rate. To name a few trends: people tend to live longer, chronic illnesses are diagnosed earlier and due to scientific progress, many fatal diseases can be controlled (if not cured). The ensuing rise of demand for care cannot be met by the existing infrastructure of hospitals. As the home care model is far more scalable than hospital care, Mediq expects to see tremendous growth of their direct-to-patient business. This will take pressure off hospital resources while relieving patients of the need to hospital visits. That means Mediq’s direct-to-patient strategy is fully aligned with the value-based healthcare methodology.
Vacancy: Transformation Manager
The Benelux organization takes part in this transformation with a program focusing on the optimization of the commercial organization, customer contact, supply chain and innovation. As the right hand of Vincent Weijers (Executive Vice President), the Transformation Manager faciltates, stimulates, motivates and accelerates the transformation agenda. He/she oversees all initiatives, coordinates cross-functional projects and acts in a “challenge and support” role towards projects owners. It’s a support function for the organization to ensure initiatives get implemented in the most pragmatic and efficient manner, allowing line functions to focus on execution. The Transformation Manager is also the first escalation level for critical issues, which means stakeholder management at all levels is key. Keeping the overview over all lines of business, this person also provides consistency to internal discussions and Board updates. An example of a strategic initiative he/she will immediately be working on is the transition to a state-of-the-art omni-channel DC in Bleiswijk (due in 2018). It will house all 20,000 products and supply them for all direct and indirect distribution channels across the Benelux.
“Affordable healthcare means continuously striving to find new efficiencies and a relentless approach to continuous innovation and improvement.” – Hans Janssen, CFO
When the transformation of marketing, sales, customer contact and supply chain starts to near completion, Mediq will be ideally situated for generating and incubating innovative concepts to improve quality and affordability of care and the lives of many patients. The Transformation Manager will become responsible for facilitating the business in the ideation, incubation and implementation of new ideas. Over the past ten years, Mediq has already successfully introduced disruptive technologies and services internationally. A good example of a value-based healthcare initiative that is now in beta stage is offering patients the opportunity to receive chemotherapy at home. Mediq set up a pilot in collaboration with Emma Children’s Hospital AMC and KinderThuisZorg. Specialist pediatric oncology nurses visited a number of young cancer patients at home to determine whether their physical condition allowed the administration of chemotherapy. If so, Mediq ensured safe delivery of the chemotherapy administration system and the medication as prepared by Emma Children’s Hospital AMC. Because patients need to go to the hospital less often, the costs of treatment are lower and the treatment becomes less stressful, which is a win-win situation.
Proven landing spot for consultants
This is a role with huge exposure throughout the business and major impact on the organizational design of Mediq. For a strategy consultant, it’s a tremendous learning opportunity at a highly competitive private equity driven multinational. They can build on their consulting experience while being able to develop an operational and private equity track record and rapidly building a network throughout the organization, which will create leads for career progression. The role is currently filled by Kristel de Ridder, who joined Mediq from A.T. Kearney. Top of Minds is now looking for her successor as De Ridder will be promoted to Head of E-Business.
Under the influence of technological, demographical and political factors, the world of healthcare is changing faster and more drastically than ever. Mediq, a leading player in health and home care across fourteen countries, responds by introducing new business models, initiatives and approaches to improve quality and affordability of care and, ultimately, the lives of millions of patients.
Mediq was founded in 1899 in the Netherlands. The private equity driven multinational has around 4000 employees and a leading position supplying medical devices, services and pharmaceuticals in every country in which it is active.
Over the coming years, Mediq’s market landscape will continue to change at an ever increasing rate. The challenge for the Corporate M&A and Business Development team is two-fold. Firstly, they will identify new business models that build on Mediq’s portfolio of strengths. The second part will be to execute organic and inorganic growth strategies to keep Mediq at the forefront of care for patients in hospital and, in particular, at home. Home care will see tremendous growth over the years to come, and Mediq will have a central position in defining and meeting this new reality.
Senior Manager Strategy and M&A
The Senior Manager is a member of the Corporate M&A and Business Development team (4 FTE). Across all current and future markets, this team is headed by Group Director Gerrit Webbink. There also is an opening for a Manager Strategy and M&A (minimum of four years of experience) within this team.
Mediq has positioned itself at the nexus of multiple vectors of innovation. The Senior Manager Strategy and M&A will have a central role in shaping Mediq’s evolution, working closely with the Executive Committee and supporting local Managing Directors and their leadership teams on strategic projects and M&A related activity.
Through strategic analysis, market landscaping, management of major, high-visibility internal projects, and deal sourcing, closing and integration, the Senior Manager will be at the forefront of major pillars of Mediq’s growth. A recent example of Mediq’s buy-and-build strategy is the acquisition of Globomedica, a leading direct-to-patient ostomy and specialty pharmaceuticals distributor in Switzerland.
Ideally, candidates will have a background in strategy consulting. Additional industry experience is an advantage. Candidates are analytical, strategic, pro-active and comfortable to work in a private equity driven environment. Maturity and authority are crucial to perform well during mergers and acquisitions and cooperation with C-level executives. Ambition is key: potential next steps could either be at HQ or towards local line management.